BROADWOOD CAPITAL INC - Q4 2015 holdings

$594 Million is the total value of BROADWOOD CAPITAL INC's 9 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 28.6% .

 Value Shares↓ Weighting
MNST  MONSTER BEVERAGE CORP NEW$238,207,000
+10.2%
1,599,1360.0%40.13%
-5.7%
MNKKQ  MALLINCKRODT PUB LTD CO$120,898,000
+16.7%
1,619,9680.0%20.37%
-0.1%
BTX BuyBIOTIME INC$82,811,000
+36.2%
21,864,396
+7.9%
13.95%
+16.6%
STAA BuySTAAR SURGICAL CO$61,739,000
-7.7%
8,646,923
+0.3%
10.40%
-21.0%
CYNO BuyCYNOSURE INCcl a$40,961,000
+52.3%
916,975
+2.4%
6.90%
+30.3%
IWM  ISHARES TRrussell 2000 etf$28,155,000
+3.1%
250,0000.0%4.74%
-11.8%
IMPR NewIMPRIVATA INC$7,554,000668,526
+100.0%
1.27%
OCX NewONCOCYTE CORPORATION$6,833,0001,093,219
+100.0%
1.15%
AST  ASTERIAS BIOTHERAPEUTICS INC$6,449,000
+1.5%
1,641,0250.0%1.09%
-13.1%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO42Q3 202359.1%
MONSTER BEVERAGE CORP NEW34Q3 202349.7%
ISHARES TR33Q3 202314.8%
ONCOCYTE CORPORATION31Q2 20234.6%
BIOTIME INC25Q2 201917.8%
AXON ENTERPRISE INC24Q3 202313.4%
AGEX THERAPEUTICS INC20Q3 20231.5%
LINEAGE CELL THERAPEUTICS INC17Q3 20235.1%
ASTERIAS BIOTHERAPEUTICS INC16Q4 20182.9%
CYNOSURE INC15Q4 201610.4%

View BROADWOOD CAPITAL INC's complete holdings history.

Latest filings
TypeFiled
42024-04-15
13F-HR2024-02-14
42024-02-08
42024-01-10
42024-01-05
42023-11-30
13F-HR2023-11-14
42023-11-14
42023-11-09
42023-11-06

View BROADWOOD CAPITAL INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (593608000.0 != 593607000.0)

Export BROADWOOD CAPITAL INC's holdings